Article thumbnail

Th17 Cells and IL-17 in Protective Immunity to Vaginal Candidiasis

By Donatella Pietrella, Anna Rachini, Mark Pines, Neelam Pandey, Paolo Mosci, Francesco Bistoni, Cristophe d'Enfert and Anna Vecchiarelli
Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2010). A beta-glucan-conjugate vaccine and anti-beta-glucan antibodies are effective against murine vaginal candidiasis as assessed by a novel in vivo imaging technique.
  2. (2009). A multifunctional, synthetic Gaussia princeps luciferase reporter for live imaging of Candida albicans infections.
  3. (1999). Analysis of vaginal cell populations during experimental vaginal candidiasis.
  4. (2007). Anticandidal immunity and vaginitis: novel opportunities for immune intervention.
  5. (2009). Casadevall A
  6. (2003). Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection.
  7. (1999). Defensins and host defense.
  8. (2010). Epithelial cell-derived S100 calcium-binding proteins as key mediators in the hallmark acute neutrophil response during Candida vaginitis.
  9. (2008). Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer.
  10. (2009). Halofuginone inhibits TH17 cell differentiation by activating the amino acid starvation response.
  11. (2000). Halofuginone: a potent inhibitor of critical steps in angiogenesis progression.
  12. (2004). History and new insights into host defense against vaginal candidiasis.
  13. (2007). History and update on host defense against vaginal candidiasis.
  14. (2005). Immunity in vaginal candidiasis.
  15. (2002). Immunology. Versatile defensins.
  16. (1996). Immunopathogenesis of recurrent vulvovaginal candidiasis.
  17. (2008). Induction and effector functions of T(H)17 cells.
  18. (2003). Influence of hormonal contraceptives on the immune cells and thickness of human vaginal epithelium.
  19. (2006). Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides.
  20. (2005). Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.
  21. (2007). Interleukin-17 as an effector molecule of innate and acquired immunity against infections.
  22. (1999). Local production of chemokines during experimental vaginal candidiasis.
  23. (2000). Local Th1/Th2 cytokine production during experimental vaginal candidiasis: potential importance of transforming growth factor-beta.
  24. (2010). Modulation of human beta-defensin-2 expression by 17beta-estradiol and progesterone in vaginal epithelial cells.
  25. (2000). Nagler A
  26. (2002). New immunotherapeutic strategies to control vaginal candidiasis.
  27. (2007). New players in the cytokine orchestra of inflammatory bowel disease.
  28. (2008). Odds FC
  29. (1991). Phenotypic analysis and gamma delta-T cell receptor repertoire of murine T cells associated with the vaginal epithelium.
  30. (2006). Phenotypic and functional characterization of vaginal dendritic cells in a rat model of Candida albicans vaginitis.
  31. (2004). Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 190: 624–631. A Protective Role for IL-17
  32. (1995). Resident CD4+ alpha beta T cells of the murine female genital tract: a phenotypically distinct T cell lineage that rapidly proliferates in response to systemic T cell activation stimuli.
  33. (2008). Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut.
  34. (2008). Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy.
  35. (2007). Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells.
  36. (2008). T cells help to amplify inflammatory responses induced by Salmonella enterica serotype Typhimurium in the intestinal mucosa.
  37. (1996). T lymphocytes in the murine vaginal mucosa are phenotypically distinct from those in the periphery.
  38. (2008). Targeting TGFb signaling to inhibit fibroblasts activation as a therapy for fibrosis and cancer.
  39. Tato CM (2010) Innate IL-17-producing cells: the sentinels of the immune system.
  40. (2007). Th17 cells and mucosal host defense.
  41. (2009). Th17 cells bounce off the fungal wall.
  42. (2006). The IL-23/IL-17 axis in inflammation.
  43. (2008). Toll-like receptors and cytokines as surrogate biomarkers for evaluating vaginal immune response following microbicide administration. Mediators Inflamm
  44. Trifilieff A (2003) IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharideinduced airway neutrophilia: IL-15 as a possible trigger.
  45. (2002). Vaginal and oral epithelial cell anti-Candida activity.
  46. (2007). Vulvovaginal candidosis.